Valeant files annual report, says in compliance with covenants
Published Fri, Apr 29, 2016 · 12:15 PM
[BENGALURU] Beleaguered Canadian drugmaker Valeant Pharmaceuticals International Inc filed its annual report on Friday, which will help it stave of a default on its US$30 billion debt.
The company said it was in compliance with its credit agreement and senior note indentures.
Valeant said no additional restatements were required beyond those previously disclosed.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Japan’s 7-Eleven convenience chain targets aggressive global growth
Bubble tea maker Chabaidao slumps 10% in Hong Kong’s biggest 2024 debut
Parental fury after stem cell bank ruins thousands of samples in Singapore
China’s bubble tea boom creates a half-dozen billionaires
US sues to block Coach owner’s US$8.5 billion buyout of Versace parent
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO